The Effects of Tacrolimus on T-Cell Proliferation Are Short-Lived: A Pilot Analysis of Immune Function Testing

Background. Optimal immunosuppression after organ transplant should balance the risks of rejection, infection, and malignancy while minimizing barriers to adherence including frequent or time-sensitive dosing. There is currently no reliable immune function assay to directly measure the degree of imm...

Full description

Bibliographic Details
Main Authors: Benjamin L. Laskin, MD, MS, Jing Jiao, BSc, H. Jorge Baluarte, MD, Sandra Amaral, MD, MHS, Susan L. Furth, MD, PhD, Tatiana Akimova, MD, PhD, Wayne W. Hancock, MD, PhD, Matthew H. Levine, MD, PhD, Peter P. Reese, MD, MSCE, Ulf H. Beier, MD
Format: Article
Language:English
Published: Wolters Kluwer 2017-08-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000715